New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2014
09:10 EDTSBRASabra Health Care backs FY14 Normalized FFO, Normalized AFFO guidance
Sabra Health Care reaffirmed its guidance ranges for Normalized FFO and Normalized AFFO per diluted common share for FY14. The reaffirmed guidance includes the impact of all investing and financing activity through May 12 and assumes that the remaining $30.1M commitment under the Forest Park Medical Center - Fort Worth construction loan is funded with the proceeds remaining from our recently completed equity offering and available cash. No other investment or financing activities are assumed in the guidance. Commenting on the reaffirmed 2014 guidance, Rick Matros, CEO and chairman, said, "We were able, from a timing perspective, to have the equity offering coincide with our investment activity to date, so that the dilution from the offering is effectively offset by the $166M in investment activity to date. We also assume we'll finish out the construction financing for the Fort Worth hospital which is $30.1M. The guidance does not include any other investment activity for the year despite our belief that our total investment activity for the year will still be in the $350M-$400M range. Additionally, the equity offering allowed us to very quickly achieve our leverage ratio goal with that ratio dropping from 5.29x to 4.14x. Our capital available for investments currently stands at over $340M inclusive of the availability under our revolving credit facility and availability under our ATM program should we choose to use that."
News For SBRA From The Last 14 Days
Check below for free stories on SBRA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 18, 2014
16:34 EDTSBRASabra comments on Genesis HealthCare's combination with Skilled Healthcare
Sabra Health Care's (SBRA) tenant, Genesis HealthCare announced that it has signed a definitive agreement to combine with Skilled Healthcare Group (SKH). According to Genesis's announcement, Skilled shareholders will collectively own 25.75% of the vote and value of the fully-diluted equity of the combined company and Genesis shareholders will own the other 74.25%. After completion of the transaction, the new company will operate under the Genesis HealthCare name and will be traded on the NYSE. The closing of the transaction is subject to regulatory approvals, expiration of the waiting period under the Hart-Scott-Rodino, or HSR, Antitrust Improvements Act of 1976, as well as other conditions. According to Genesis's announcement, the closing of the combination is expected to occur in early 2015. Commenting on the proposed transaction, Rick Matros, CEO and Chairman, said "We believe the quality of our tenant base, including our existing parent guaranty from Genesis, is only strengthened by this transaction and our shareholders will benefit by the enhanced transparency of Genesis being a publicly-traded company. Genesis is a leading operator in the sector and we view this transaction favorably."

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use